Speaker illustration

Ms Pauline Puylaert

University of Antwerp, Antwerp (Belgium)

Understanding the role of RIPK1 kinase activity in atherogenesis: a genetic versus pharmacological approach

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Moderated poster 12 - Vascular Diseases


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb